HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Haibel Selected Research

Etanercept (Enbrel)

7/2011Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.
4/2011Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.
12/2005Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
3/2005Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
6/2003Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Haibel Research Topics

Disease

21Ankylosing Spondylitis
01/2019 - 06/2000
5Inflammation (Inflammations)
07/2011 - 11/2002
5Necrosis
06/2011 - 11/2000
4Axial Spondyloarthritis
11/2019 - 04/2011
2Spondylarthritis (Spinal Arthritis)
02/2020 - 06/2003
2Ankylosis
07/2011 - 06/2000
2Rheumatoid Arthritis
09/2010 - 07/2009
2Arthritis (Polyarthritis)
09/2006 - 01/2005
2Pain (Aches)
03/2005 - 06/2003
2Spondylarthropathies
11/2000 - 06/2000
1Arthralgia (Joint Pain)
05/2018
1Body Weight (Weight, Body)
03/2008
1Crohn Disease (Crohn's Disease)
05/2007
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2007
1Ulcerative Colitis
05/2007
1Back Pain (Backache)
09/2006
1Osteoporosis
11/2002

Drug/Important Bio-Agent (IBA)

7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007 - 06/2000
6Infliximab (Remicade)FDA Link
03/2008 - 06/2000
5Etanercept (Enbrel)FDA Link
07/2011 - 06/2003
4Sulfasalazine (Azulfidine)FDA LinkGeneric
07/2011 - 09/2006
3Antirheumatic Agents (DMARD)IBA
09/2010 - 03/2007
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2019 - 02/2005
2C-Reactive ProteinIBA
06/2011 - 06/2003
2Methotrexate (Mexate)FDA LinkGeneric
09/2010 - 03/2007
2Therapeutic UsesIBA
03/2007 - 02/2005
2Proteins (Proteins, Gene)FDA Link
12/2005 - 03/2005
1Tumor Necrosis Factor InhibitorsIBA
02/2020
1secukinumabIBA
01/2019
1CytokinesIBA
05/2018
1Cytokine Receptors (Cytokine Receptor)IBA
05/2018
1Prednisolone (Predate)FDA LinkGeneric
01/2014
1Adalimumab (Humira)FDA Link
08/2013
1N 30IBA
07/2011
1Abatacept (Orencia)FDA Link
06/2011
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
09/2006
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2005
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2005
1Interleukin-1 (Interleukin 1)IBA
02/2005
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2005
1Leflunomide (Arava)FDA LinkGeneric
01/2005
1Pamidronate (Aredia)FDA LinkGeneric
08/2003
1Diphosphonates (Bisphosphonates)IBA
11/2002
1AntibodiesIBA
11/2000
1Monoclonal AntibodiesIBA
06/2000

Therapy/Procedure

6Therapeutics
11/2019 - 06/2000
1Retreatment
08/2013
1Subcutaneous Injections
03/2007